NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor ?1.
Ontology highlight
ABSTRACT: Thyroid hormone receptor ? (THRA) gene mutations, via dominant negative mode, cause erythroid abnormalities in patients. Using mice expressing a dominant negative TR?1 mutant (TR?1PV; Thra1 PV/+ mice), we showed that TR?1PV acted directly to suppress the expression of key erythroid genes, causing erythroid defects. The nuclear receptor corepressor 1 (NCOR1) was reported to mediate the dominant negative effects of mutated TR?1. However, how NCOR1 could regulate TR?1 mutants in erythroid defects in vivo is not known. In the present study, we crossed Thra1 PV/+ mice with mice expressing a mutant Ncor1 allele (NCOR1?ID; Ncor1 ?ID mice). TR?1PV mutant cannot bind to NCOR1?ID. The expression of NCOR1?ID ameliorated abnormalities in the peripheral blood indices, and corrected the defective differentiation potential of progenitors in the erythroid lineage. The defective terminal erythropoiesis of lineage-negative bone marrow cells of Thra1 PV/+ mice was rescued by the expression of NCOR1?ID. De-repression of key erythroid genes in Thra1 PV/+ Ncor1 ?ID/?ID mice led to partial rescue of terminal erythroid differentiation. These results indicate that the inability of TR?1PV to recruit NCOR1?ID to form a repressor complex relieved the deleterious actions of TR?1 mutants in vivo. NCOR1 is a critical novel regulator underpining the pathogenesis of erythroid abnormalities caused by TR?1 mutants.
SUBMITTER: Han CR
PROVIDER: S-EPMC5741760 | biostudies-other | 2017 Dec
REPOSITORIES: biostudies-other
ACCESS DATA